查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1361754

全球人工智慧 (AI) 药物发现市场报告

Global Artificial Intelligence (AI) in Drug Discovery Market Report
出版日期: | 出版商: Value Market Research | 英文 286 Pages | 商品交期: 最快1-2个工作天内

价格

预计到2030年，全球药物发现市场对人工智慧（AI）的需求将从2022年的11.9亿美元达到近272.5亿美元的市场规模，2023年至2030年的研究期间复合年增长率为47.9%。

药物发现中的人工智慧（AI）是一种利用机器模拟人类智慧来解决药物发现过程中具有挑战性问题的技术。该技术有助于发现新化合物，并有助于识别治疗标靶和开发定製药物。该系统有许多应用，包括深入了解药物识别和减轻各种慢性疾病的严重程度。该市场包括用于药物发现销售和相关服务的人工智慧。

市场动态：

推动人工智慧在药物输送市场成长的一些主要驱动因素包括基于云端的应用程式和服务的使用不断增加以及重磅药品的专利即将到期。推动需求的其他因素包括控制药物发现成本的需求不断增长以及药物开发所需时间的减少。此外，由于新型药物疗法的发现和开发以及生命科学产业製造能力的不断扩大，技术需求也在不断增长。然而，预计未来几年，一些问题将阻碍该行业的发展，包括缺乏熟练的人工智慧工人、医疗软体的监管要求不明确以及该领域缺乏资料集。儘管如此，跨产业合作的日益频繁将成为影响市场发展速度的主要驱动力。

该报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对药物发现领域人工智慧 (ai) 全球市场的各个细分市场进行了包容性评估。人工智慧 (AI) 在药物发现行业的成长和趋势为这项研究提供了整体方法。

区域分析：

本节涵盖区域展望，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲药物发现市场对人工智慧 (AI) 的当前和未来需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。药物发现市场人工智慧（ai）的主要参与者包括微软公司（美国）、Exscientia（英国）、NVIDIA公司（美国）、薛丁格（美国）、Atomwise公司（美国）、BenevolentAI（英国）、 NuMedii（美国） 、Google（美国）、Insilico Medicine（美国）、BERG LLC（美国）、Cloud Pharmaceuticals（美国）、Cyclica（加拿大）、Deep Genomics（加拿大）、IBM（美国）、BIOAGE（美国）、Valo Health（美国） 、Envisagenics（美国）、twoXAR（美国）、XtalPi（美国）、Verge Genomics（美国）、Owkin, Inc.（美国）、Biovista（美国）、Evaxion Biotech（丹麦）、Iktos（法国）、 Standigm（韩国）和BenchSci（加拿大）。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：药物发现中的人工智慧 (AI) - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品提供的市场吸引力分析
    • 按技术分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：药物发现市场分析中的全球人工智慧 (AI)：透过提供

  • 按产品分类概述
  • 历史和预测数据
  • 按产品分析
  • 软体
  • 服务

第 6 章：药物发现市场分析中的全球人工智慧 (AI)：按技术分类

  • 依技术概述
  • 历史和预测数据
  • 依技术分析
  • 机器学习
  • 深度学习
  • 监督学习
  • 强化学习
  • 无监督学习
  • 其他机器学习技术
  • 其他技术

第 7 章：药物发现市场分析中的全球人工智慧 (AI)：按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 8 章：药物发现公司中人工智慧 (AI) 的竞争格局

  • 药物发现市场竞争中的人工智慧（Ai）
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 9 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Microsoft Corporation (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Exscientia (UK)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • NVIDIA Corporation (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Schrodinger (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Atomwise Inc. (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • BenevolentAI (UK)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • NuMedii (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Google (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Insilico Medicine (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • BERG LLC (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Cloud Pharmaceuticals (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Cyclica (Canada)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Deep Genomics (Canada)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • IBM (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • BIOAGE (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Valo Health (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Envisagenics (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • twoXAR (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • XtalPi (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Verge Genomics (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Owkin Inc. (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Biovista (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Evaxion Biotech (Denmark)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Iktos (France)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Standigm (South Korea)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • BenchSci (Canada)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

Product Code: VMR11218721

The global demand for Artificial Intelligence (AI) in Drug Discovery Market is presumed to reach the market size of nearly USD 27.25 BN by 2030 from USD 1.19 BN in 2022 with a CAGR of 47.9% under the study period of 2023 - 2030.

Artificial intelligence (AI) in Drug Discovery is a technology that employs machines to simulate human intelligence to solve challenging issues in the drug discovery process. The technology helps in discovering novel compounds and aids in the identification of therapeutic targets and the development of tailored medications. The system has numerous applications, including deriving insights into identifying drugs and lessening the severity of various chronic diseases. This market includes AI for drug discovery sales and related services.

MARKET DYNAMICS:

Some of the main drivers propelling the growth of AI in the drug delivery market include the rising usage of cloud-based applications and services and the impending patent expiration of blockbuster pharmaceuticals. Additional factors boosting demand are the growing need to control drug discovery costs and less time required for drug development. Further, the technology demand is also rising due to the discovery and development of novel pharmacological therapies and the expanding manufacturing capabilities of the life science industry. However, several problems are anticipated to impede the growth of this industry in the years to come, including a lack of skilled AI workers, hazy regulatory requirements for medical software, and a lack of data sets in this area. Nonetheless, the growing frequency of cross-industry partnerships will be a major driver influencing the market's development rate.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of artificial intelligence ( ai) in drug discovery. The growth and trends of Artificial Intelligence ( AI) in Drug Discovery Industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the artificial intelligence ( ai) in drug discovery market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Offering

  • Software
  • Services

By Technology

  • Machine Learning
  • Deep Learning
  • Supervised Learning
  • Reinforcement Learning
  • Unsupervised Learning
  • Other Machine Learning Technologies
  • Other Technologies

By Application

  • Immuno-Oncology
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Metabolic Diseases
  • Other Applications

By End User

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Research Centers And Academic & Government Institutes

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Artificial Intelligence ( AI) in Drug Discovery market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the artificial intelligence ( ai) in drug discovery market include Microsoft Corporation (US), Exscientia (UK), NVIDIA Corporation (US), Schrodinger (US), Atomwise, Inc. (US), BenevolentAI (UK), NuMedii (US), Google (US), Insilico Medicine (US), BERG LLC (US), Cloud Pharmaceuticals (US), Cyclica (Canada), Deep Genomics (Canada), IBM (US), BIOAGE (US), Valo Health (US), Envisagenics (US), twoXAR (US), XtalPi (US), Verge Genomics (US), Owkin, Inc. (US), Biovista (US), Evaxion Biotech (Denmark), Iktos (France), Standigm (South Korea), and BenchSci (Canada). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Offering
    • 3.7.2 Market Attractiveness Analysis By Technology
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ANALYSIS BY OFFERING

  • 5.1 Overview by Offering
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Offering
  • 5.4 Software Historic and Forecast Sales by Regions
  • 5.5 Services Historic and Forecast Sales by Regions

6 . GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ANALYSIS BY TECHNOLOGY

  • 6.1 Overview by Technology
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Technology
  • 6.4 Machine Learning Historic and Forecast Sales by Regions
  • 6.5 Deep Learning Historic and Forecast Sales by Regions
  • 6.6 Supervised Learning Historic and Forecast Sales by Regions
  • 6.7 Reinforcement Learning Historic and Forecast Sales by Regions
  • 6.8 Unsupervised Learning Historic and Forecast Sales by Regions
  • 6.9 Other Machine Learning Technologies Historic and Forecast Sales by Regions
  • 6.10. Other Technologies Historic and Forecast Sales by Regions

7 . GLOBAL ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY COMPANIES

  • 8.1. Artificial Intelligence (Ai) In Drug Discovery Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Microsoft Corporation (US)
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Exscientia (UK)
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. NVIDIA Corporation (US)
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Schrodinger (US)
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Atomwise Inc. (US)
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. BenevolentAI (UK)
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. NuMedii (US)
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Google (US)
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. Insilico Medicine (US)
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. BERG LLC (US)
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments
  • 9.13. Cloud Pharmaceuticals (US)
    • 9.13.1. Company Overview
    • 9.13.2. Company Revenue
    • 9.13.3. Products
    • 9.13.4. Recent Developments
  • 9.14. Cyclica (Canada)
    • 9.14.1. Company Overview
    • 9.14.2. Company Revenue
    • 9.14.3. Products
    • 9.14.4. Recent Developments
  • 9.15. Deep Genomics (Canada)
    • 9.15.1. Company Overview
    • 9.15.2. Company Revenue
    • 9.15.3. Products
    • 9.15.4. Recent Developments
  • 9.16. IBM (US)
    • 9.16.1. Company Overview
    • 9.16.2. Company Revenue
    • 9.16.3. Products
    • 9.16.4. Recent Developments
  • 9.17. BIOAGE (US)
    • 9.17.1. Company Overview
    • 9.17.2. Company Revenue
    • 9.17.3. Products
    • 9.17.4. Recent Developments
  • 9.18. Valo Health (US)
    • 9.18.1. Company Overview
    • 9.18.2. Company Revenue
    • 9.18.3. Products
    • 9.18.4. Recent Developments
  • 9.19. Envisagenics (US)
    • 9.19.1. Company Overview
    • 9.19.2. Company Revenue
    • 9.19.3. Products
    • 9.19.4. Recent Developments
  • 9.20. twoXAR (US)
    • 9.20.1. Company Overview
    • 9.20.2. Company Revenue
    • 9.20.3. Products
    • 9.20.4. Recent Developments
  • 9.21. XtalPi (US)
    • 9.21.1. Company Overview
    • 9.21.2. Company Revenue
    • 9.21.3. Products
    • 9.21.4. Recent Developments
  • 9.22. Verge Genomics (US)
    • 9.22.1. Company Overview
    • 9.22.2. Company Revenue
    • 9.22.3. Products
    • 9.22.4. Recent Developments
  • 9.23. Owkin Inc. (US)
    • 9.23.1. Company Overview
    • 9.23.2. Company Revenue
    • 9.23.3. Products
    • 9.23.4. Recent Developments
  • 9.24. Biovista (US)
    • 9.24.1. Company Overview
    • 9.24.2. Company Revenue
    • 9.24.3. Products
    • 9.24.4. Recent Developments
  • 9.25. Evaxion Biotech (Denmark)
    • 9.25.1. Company Overview
    • 9.25.2. Company Revenue
    • 9.25.3. Products
    • 9.25.4. Recent Developments
  • 9.26. Iktos (France)
    • 9.26.1. Company Overview
    • 9.26.2. Company Revenue
    • 9.26.3. Products
    • 9.26.4. Recent Developments
  • 9.27. Standigm (South Korea)
    • 9.27.1. Company Overview
    • 9.27.2. Company Revenue
    • 9.27.3. Products
    • 9.27.4. Recent Developments
  • 9.28. BenchSci (Canada)
    • 9.28.1. Company Overview
    • 9.28.2. Company Revenue
    • 9.28.3. Products
    • 9.28.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Offering (USD MN)
  • Software Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Analysis Market by Technology (USD MN)
  • Machine Learning Market Sales by Geography (USD MN)
  • Deep Learning Market Sales by Geography (USD MN)
  • Supervised Learning Market Sales by Geography (USD MN)
  • Reinforcement Learning Market Sales by Geography (USD MN)
  • Unsupervised Learning Market Sales by Geography (USD MN)
  • Other Machine Learning Technologies Market Sales by Geography (USD MN)
  • Other Technologies Market Sales by Geography (USD MN)
  • Global Artificial Intelligence (Ai) In Drug Discovery Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Artificial Intelligence (Ai) In Drug Discovery Report
  • Market Research Process
  • Market Research Methodology
  • Global Artificial Intelligence (Ai) In Drug Discovery Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Offering
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Offering (USD MN)
  • Software Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Technology (USD MN)
  • Machine Learning Market Sales by Geography (USD MN)
  • Deep Learning Market Sales by Geography (USD MN)
  • Supervised Learning Market Sales by Geography (USD MN)
  • Reinforcement Learning Market Sales by Geography (USD MN)
  • Unsupervised Learning Market Sales by Geography (USD MN)
  • Other Machine Learning Technologies Market Sales by Geography (USD MN)
  • Other Technologies Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.